Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression
Clinical trial NCT04400058 · COMPLETED
Trial details
- NCT number
- NCT04400058
- Sponsor
- Octapharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2022-02-01
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.